Back to the news list
17 March 2020

Our factories are open

In the current context of a pandemic, strict confinement measures have been given in France and certain countries. We want to reassure you about the continuity of our business and our ability to meet your needs of isothermal solutions for the transport of medicines.

As a supplier and partner to many pharmaceutical companies, we shall continue our activity while strengt

hening the hygiene and health measures recommended to protect our staff.

Today we have sufficient stock of raw materials and finished products, on-going supplies, available carriers and production teams fully mobilized to meet your needs.

Our 8 production sites are operational on 4 continents: USA (Philadelphia), Brazil (Sao Paolo), France (St Georges de Reneins), UK (Leigh-on-Sea), Germany (Neunkirchen), India (Bangalore), China (Shanghai) and Singapore.

Our sales teams can be reached by email and phone.

The unprecedented situation in which we find ourselves nevertheless leads us to be cautious and we will keep you informed in case of change.

Other news

06 March 2024

Join EMBALL'ISO at Logipharma

We're delighted to announce our participation in LogiPharma, the world’s leading life sciences supply chain event, at the Lyon Convention Center from April 16 to 18, 2024 !
Read more
27 September 2023

Discover the list of events we'll be attending in October 2023!

 From October 4th to 6th, 2023, we'll be exhibiting at Logipharma US in Boston, Booth 110.
Read more
25 August 2023

Proudly Engaging in ESG Conversations for Sustainable Pharma Growth

We are thrilled to share our recent engagement in an interview on the topic of "How ESG can drive sustainable growth in the pharmaceutical sector”.
Read more
04 August 2023

Excited to be a part of Pharma.Aero's First Episode on Environmental Sustainability Podcast Series !

Florence Lehec, Head of Marketing at EMBALL’ISO has been invited as a guest on Pharma.Aero's podcast, where we delved into the crucial topic of environmental sustainability within the healthcare supply chain.
Read more